BST2 and oral cavity squamous cell carcinoma: Additionally, studies on oral squamous cell carcinoma (OSCC) have shown that BST2 not only directly promotes the malignant phenotype of tumor cells but also suggests its role in remodeling the tumor immune microenvironment, as indicated by the enrichment characteristics of its immune-related pathways [37].